PharmaCielo Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PharmaCielo Ltd. generated cash of -$5,149,774, which is more than the previous year. Cash used in financing activities reached the amount of $4,628,276 last year. Net change in cash is therefore -$110,804.
Cash Flow
| 2017 | -19.91K | 0 | 107K |
|---|---|---|---|
| 2018 | -78.46K | 0 | 199.59K |
| 2019 | -25.16M | -11.26M | 4.51M |
| 2020 | -22.56M | -5.57M | 23.32M |
| 2021 | -20.07M | -1.65M | 18.20M |
| 2022 | -9.70M | -725.48K | 5.29M |
| 2023 | -5.14M | 391.63K | 4.62M |
PCLO.V Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 172.98K | 5.33M | 8.85M | 13.67M | 45.67M | 87.08K | 0 |
Operating activities | |||||||
Net income | -16.29M | -14.51M | -26.62M | -43.75M | -34.66M | -144.39K | -15.98K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 1.41M | 1.57M | 1.25M | 1.56M | 1.28M | 0 | 0 |
Stock-based compensation expense | 1.53M | 2.20M | 6.82M | 6.48M | 11.31M | 0 | 0 |
| Deferred income tax benefit | 1.53M | 2.20M | 6.82M | 6.48M | 11.31M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 803.64K | -399.8K | 125.47K | -1.98M | -709.49K | 0 | 0 |
Inventories | 746.05K | -1.00M | -3.42M | -4.71M | -2.72M | 0 | 0 |
Accounts payable | 0 | -349.18K | -4.47M | 9.77M | 0 | 10.01K | 0 |
Cash generated by operating activities | -5.14M | -9.70M | -20.07M | -22.56M | -25.16M | -78.46K | -19.91K |
Investing activities | |||||||
Purchases Of Investments | 0 | -203.62K | -546.28K | -500K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -15.26K | -521.86K | -1.13M | -5.43M | -10.71M | 0 | 0 |
Acquisitions Net | 0 | 0 | -1.29M | -1.04M | -551.63K | 0 | 0 |
Cash generated by investing activities | 391.63K | -725.48K | -1.65M | -5.57M | -11.26M | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 0 | 83.2K | 13.54M | 20.36M | 4.77M | 199.59K | 107K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 4.92M | 5.17M | -387.54K | -261.03K | -261.52K | 0 | 0 |
Cash used in financing activities | 4.62M | 5.29M | 18.20M | 23.32M | 4.51M | 199.59K | 107K |
Net Change In Cash | -110.80K | -5.16M | -3.52M | -4.81M | -32.00M | 121.12K | 87.08K |
Cash at end of period | 62.17K | 172.98K | 5.33M | 8.85M | 13.67M | 208.21K | 87.08K |